Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian C Aichelburg

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal of STD & AIDS|September 13, 2013
Enhanced therapy for primary and secondary syphilis: a longitudinal retrospective analysis of cure rates and associated factorsJulia Tittes, Maximilian C Aichelburg, Lukasz Antoniewicz, et al.
The Journal of Infectious Diseases|August 6, 2013
Reversion and conversion of interferon-γ release assay results in HIV-1-infected individualsMaximilian C Aichelburg, Thomas Reiberger, Florian Breitenecker, et al.
Journal of Clinical Microbiology|May 18, 2012
Prognostic value of indeterminate IFN-γ release assay results in HIV-1 infectionMaximilian C Aichelburg, Julia Tittes, Florian Breitenecker, et al.
Plos One|April 12, 2016
Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, AustriaSandra Herout, Mattias Mandorfer, Florian Breitenecker, et al.
Plos One|September 1, 2015
Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected IndividualsMaximilian C Aichelburg, Lukas Weseslindtner, Mattias Mandorfer, et al.
Wiener Klinische Wochenschrift|December 15, 2015
Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failureMattias Mandorfer, Sebastian Steiner, Philipp Schwabl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2009
Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individualsMaximilian C Aichelburg, Armin Rieger, Florian Breitenecker, et al.
Antiviral Therapy|September 6, 2012
A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirinThomas Reiberger, Berit A Payer, Arnulf Ferlitsch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2013
Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirinMattias Mandorfer, Berit A Payer, Bernhard Scheiner, et al.
AIDS (London, England)|January 13, 2017
Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial functionChristopher Schuster, Christina Binder, Robert Strassl, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of STD & AIDS|September 13, 2013
Enhanced therapy for primary and secondary syphilis: a longitudinal retrospective analysis of cure rates and associated factorsJulia Tittes, Maximilian C Aichelburg, Lukasz Antoniewicz, et al.
The Journal of Infectious Diseases|August 6, 2013
Reversion and conversion of interferon-γ release assay results in HIV-1-infected individualsMaximilian C Aichelburg, Thomas Reiberger, Florian Breitenecker, et al.
Journal of Clinical Microbiology|May 18, 2012
Prognostic value of indeterminate IFN-γ release assay results in HIV-1 infectionMaximilian C Aichelburg, Julia Tittes, Florian Breitenecker, et al.
Plos One|April 12, 2016
Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, AustriaSandra Herout, Mattias Mandorfer, Florian Breitenecker, et al.
Plos One|September 1, 2015
Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected IndividualsMaximilian C Aichelburg, Lukas Weseslindtner, Mattias Mandorfer, et al.
Wiener Klinische Wochenschrift|December 15, 2015
Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failureMattias Mandorfer, Sebastian Steiner, Philipp Schwabl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2009
Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individualsMaximilian C Aichelburg, Armin Rieger, Florian Breitenecker, et al.
Antiviral Therapy|September 6, 2012
A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirinThomas Reiberger, Berit A Payer, Arnulf Ferlitsch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2013
Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirinMattias Mandorfer, Berit A Payer, Bernhard Scheiner, et al.
AIDS (London, England)|January 13, 2017
Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial functionChristopher Schuster, Christina Binder, Robert Strassl, et al.
Pageof 3